EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Mechanisms of Metabolic Reprogramming Regulating Immunosuppression in the Gastric Cancer Tumor Microenvironment

Wenting Dong iD, Xuepeng Qian iD, Honglin Liu iD, Jinhai Huo iD, Weiming Wang iD

Biomolecules · 2026

DOI: 10.3390/biom16010160 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules, 2026. Verfasst von Wenting Dong und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Chinese Materia Medica, Heilongjiang Academy of Chinese Medicine Science, Harbin 150036, China. Hauptthemen laut MEDLINE: Tumor Microenvironment, Stomach Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 226 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Key Science and Technology Program of Heilongjiang Province, China, 2025 Provincial Natural Science Foundation Joint Fund Key Project, Heilongjiang Province, China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immunotherapy, especially immune checkpoint inhibitors (ICIs), has become one of the core therapeutic approaches in cancer in recent years. It demonstrates remarkable efficacy in the treatment of melanoma and lung cancer. Conversely, its use in treating gastric cancer (GC) is not associated with considerable benefits. The high heterogeneity of GC and the tumor microenvironment (TME) may directly influence this phenomenon. This review focuses on the correlation between Helicobacter pylori (H. pylori) infection, gastric physiology, and molecular subtype-specific induction pathways, with emphasis on the unique metabolic features of GC. It explores the connection of H. pylori infection, gastric physiologic functions, and molecular subtype-specific induction mechanism of GC with the special metabolism of GC. It also explains the relationship between immune metabolic reprogramming and the suppressive TME in GC. Crucially, we summarize emerging therapeutic strategies targeting metabolic vulnerabilities. Furthermore, we explore the potential of subtype-guided metabolic therapies to overcome the challenges of the immunosuppressive tumor microenvironment in GC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor MicroenvironmentStomach NeoplasmsHumansMetabolic ReprogrammingHelicobacter pyloriHelicobacter InfectionsImmunotherapyAnimalsImmunosuppression Therapy

Stichwörter der Autor:innen

Helicobacter pylorigastric cancerimmune microenvironmentmetabolic reprogrammingmolecular subtypestherapeutic strategies

Autor:innen und Institutionen

  • Institute of Chinese Materia Medica, Heilongjiang Academy of Chinese Medicine Science, Harbin 150036, China.

ORCID-Profile: Wenting Dong, Xuepeng Qian, Honglin Liu, Jinhai Huo, Weiming Wang

Förderung

  • the Key Science and Technology Program of Heilongjiang Province, China
  • 2025 Provincial Natural Science Foundation Joint Fund Key Project, Heilongjiang Province, China

Zitieren

APA

Dong, W., Qian, X., Liu, H., Huo, J., & Wang, W. (2026). Mechanisms of Metabolic Reprogramming Regulating Immunosuppression in the Gastric Cancer Tumor Microenvironment. Biomolecules. https://doi.org/10.3390/biom16010160

Vancouver

Dong W, Qian X, Liu H, Huo J, Wang W. Mechanisms of Metabolic Reprogramming Regulating Immunosuppression in the Gastric Cancer Tumor Microenvironment. Biomolecules. 2026. doi:10.3390/biom16010160

BibTeX
@article{Dong2026,
  author = {Dong, Wenting and Qian, Xuepeng and Liu, Honglin and Huo, Jinhai and Wang, Weiming},
  title = {Mechanisms of Metabolic Reprogramming Regulating Immunosuppression in the Gastric Cancer Tumor Microenvironment},
  journal = {Biomolecules},
  year = {2026},
  doi = {10.3390/biom16010160}
}
Kostenlos starten →